The story of Sildenafil offers a complicated case study for investors eyeing drug companies. While first sales were explosive, present patent expiry and the arrival of generic versions have significantly influenced https://tomasjmfx309381.review-blogger.com/62605598/sildenafil-and-the-pharmaceutical-industry-a-risky-stake